Related references
Note: Only part of the references are listed.Impact of tumor grade on pancreatic neuroendocrine tumors
Bor-Shiuan Shyr et al.
ASIAN JOURNAL OF SURGERY (2022)
Multiple Endocrine Neoplasia Type 1: Latest Insights
Maria Luisa Brandi et al.
ENDOCRINE REVIEWS (2021)
Trends in Incidence and Survival of Patients with Pancreatic Neuroendocrine Neoplasm, 1987-2016
Jingxuan Wang et al.
JOURNAL OF ONCOLOGY (2021)
Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated Death
Sami Matrood et al.
NEUROENDOCRINOLOGY (2021)
The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Keisuke Yamamoto et al.
NATURE (2020)
Chloroquine induces apoptosis in pancreatic neuroendocrine neoplasms via endoplasmic reticulum stress
Kenzo Nakano et al.
ENDOCRINE-RELATED CANCER (2020)
Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
Lingaku Lee et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
The Roles of Autophagy in Cancer
Chul Won Yun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
Chang S. Chan et al.
NATURE COMMUNICATIONS (2018)
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
Aatur D. Singhi et al.
CLINICAL CANCER RESEARCH (2017)
Autophagy Inhibition Improves Sunitinib Efficacy in Pancreatic Neuroendocrine Tumors via a Lysosome-dependent Mechanism
Tabea Wiedmer et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
Ilaria Marinoni et al.
GASTROENTEROLOGY (2014)
KRAS and DAXX/ATRX Gene Mutations Are Correlated with the Clinicopathological Features, Advanced Diseases, and Poor Prognosis in Chinese Patients with Pancreatic Neuroendocrine Tumors
Fei Yuan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Expression of PTEN and mTOR in pancreatic neuroendocrine tumors
Xu Han et al.
TUMOR BIOLOGY (2013)
The prevention and handling of the missing data
Hyun Kang
KOREAN JOURNAL OF ANESTHESIOLOGY (2013)
Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells
Zhengzhi Zou et al.
AUTOPHAGY (2012)
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Christopher M. Heaphy et al.
SCIENCE (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases
Vincenzo Corbo et al.
ENDOCRINE-RELATED CANCER (2010)
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Edoardo Missiaglia et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model
Ruifang Mi et al.
JOURNAL OF GENETICS AND GENOMICS (2009)
Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression
L Ma et al.
GENES & DEVELOPMENT (2005)
Share Paper
